Diane Vrattos is the founder of Walden Biosciences. Walden Biosciences has raised $51M in total funding. Latest round: Series A. Based in Cambridge, USA.
Diane Vrattos is the CEO of Walden Biosciences, a biotechnology company based in Cambridge, Massachusetts. The company focuses on developing targeted therapies for rare and common kidney diseases. She leads the company which launched with $51 million in Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library